1: Eggert ML, Wallaschofski H, Grotevendt A, Nauck M, Volzke H, Samietz S,

Friedrich N. Cross-sectional and longitudinal relations of insulin-like growth

factor-I and IGF binding protein 3 with lipid metabolism. Eur J Endocrinol. 2014

Apr 17. [Epub ahead of print] PubMed PMID: 24743393.



2: Baxter RC. IGF binding proteins in cancer: mechanistic and clinical insights.

Nat Rev Cancer. 2014 Apr 10. doi: 10.1038/nrc3720. [Epub ahead of print] PubMed

PMID: 24722429.



3: Cusick MF, Libbey JE, Trede NS, Fujinami RS. Targeting insulin-like growth

factor 1 leads to amelioration of inflammatory demyelinating disease. PLoS One.

2014 Apr 9;9(4):e94486. doi: 10.1371/journal.pone.0094486. eCollection 2014.

PubMed PMID: 24718491; PubMed Central PMCID: PMC3981810.



4: Shirakawa J, Okuyama T, Yoshida E, Shimizu M, Horigome Y, Tuno T, Hayasaka M,

Abe S, Fuse M, Togashi Y, Terauchi Y. Effects of the antitumor drug OSI-906, a

dual inhibitor of IGF-1 receptor and insulin receptor, on the glycemic control, β

cell functions, and β cell proliferation in male mice. Endocrinology. 2014 Apr

8:en20132032. [Epub ahead of print] PubMed PMID: 24712877.



5: Clayton P, Gill, Tillmann V, Westwood M. Translational Neuroendocrinology:

Control of Human Growth. J Neuroendocrinol. 2014 Apr 3. doi: 10.1111/jne.12156.

[Epub ahead of print] PubMed PMID: 24698533.



6: Yang Y, Yee D. IGF-I Regulates Redox Status in Breast Cancer Cells by

Activating the Amino Acid Transport Molecule xC-. Cancer Res. 2014 Apr

15;74(8):2295-305. doi: 10.1158/0008-5472.CAN-13-1803. Epub 2014 Mar 31. PubMed

PMID: 24686172.



7: Tatar M, Post S, Yu K. Nutrient control of Drosophila longevity. Trends

Endocrinol Metab. 2014 Mar 27. pii: S1043-2760(14)00042-3. doi:

10.1016/j.tem.2014.02.006. [Epub ahead of print] Review. PubMed PMID: 24685228.



8: Sciacca L, Cassarino MF, Genua M, Vigneri P, Giovanna Pennisi M, Malandrino P,

Squatrito S, Pezzino V, Vigneri R. Biological Effects of Insulin and Its Analogs

on Cancer Cells With Different Insulin Family Receptor Expression. J Cell

Physiol. 2014 Mar 28. doi: 10.1002/jcp.24635. [Epub ahead of print] PubMed PMID:




9: Xu JW, Wang TX, You L, Zheng LF, Shu H, Zhang TP, Zhao YP. Insulin-Like Growth

Factor 1 Receptor (IGF-1R) as a Target of MiR-497 and Plasma IGF-1R Levels

Associated with TNM Stage of Pancreatic Cancer. PLoS One. 2014 Mar

25;9(3):e92847. doi: 10.1371/journal.pone.0092847. eCollection 2014. PubMed PMID:

24667580; PubMed Central PMCID: PMC3965476.



10: Teissier R, Flechtner I, Colmenares A, Lambot K, Baujat G, Pauwels C,

Samara-Boustani D, Beltrand J, Simon A, Thalassinos C, Crosnier H, Latrech H,

Pinto G, Le Merrer M, Cormier-Daire V, Souberbielle J, Polak M. Characterization

and Prevalence of Severe Primary IGF-1 Deficiency in a Large Cohort of French

Children with Short Stature. Eur J Endocrinol. 2014 Mar 24. [Epub ahead of print]

PubMed PMID: 24662318.



11: Chen J, Alberts I, Li X. Dysregulation of the IGF-I/PI3K/AKT/mTOR signaling

pathway in autism spectrum disorders. Int J Dev Neurosci. 2014 Mar 21;35C:35-41.

doi: 10.1016/j.ijdevneu.2014.03.006. [Epub ahead of print] Review. PubMed PMID:




12: Mountzios G, Aivazi D, Kostopoulos I, Kourea HP, Kouvatseas G, Timotheadou E,

Zebekakis P, Efstratiou I, Gogas H, Vamvouka C, Chrisafi S, Stofas A,

Pentheroudakis G, Koutras A, Galani E, Bafaloukos D, Fountzilas G. Differential

Expression of the Insulin-Like Growth Factor Receptor among Early Breast Cancer

Subtypes. PLoS One. 2014 Mar 17;9(3):e91407. doi: 10.1371/journal.pone.0091407.

eCollection 2014. PubMed PMID: 24637962; PubMed Central PMCID: PMC3956672.



13: Khwaja OS, Ho E, Barnes KV, O'Leary HM, Pereira LM, Finkelstein Y, Nelson CA

3rd, Vogel-Farley V, Degregorio G, Holm IA, Khatwa U, Kapur K, Alexander ME,

Finnegan DM, Cantwell NG, Walco AC, Rappaport L, Gregas M, Fichorova RN, Shannon

MW, Sur M, Kaufmann WE. Safety, pharmacokinetics, and preliminary assessment of

efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett

syndrome. Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):4596-601. doi:

10.1073/pnas.1311141111. Epub 2014 Mar 12. PubMed PMID: 24623853; PubMed Central

PMCID: PMC3970488.



14: Milman S, Atzmon G, Huffman DM, Wan J, Crandall JP, Cohen P, Barzilai N. Low

insulin-like growth factor-1 level predicts survival in humans with exceptional

longevity. Aging Cell. 2014 Mar 12. doi: 10.1111/acel.12213. [Epub ahead of

print] PubMed PMID: 24618355.



15: Ong J, Salomon J, Te Morsche RH, Roelofs HM, Witteman BJ, Dura P, Lacko M,

Peters WH. Polymorphisms in the insulin-like growth factor axis are associated

with gastrointestinal cancer. PLoS One. 2014 Mar 7;9(3):e90916. doi:

10.1371/journal.pone.0090916. eCollection 2014. PubMed PMID: 24608110; PubMed

Central PMCID: PMC3946608.



16: Levine ME, Suarez JA, Brandhorst S, Balasubramanian P, Cheng CW, Madia F,

Fontana L, Mirisola MG, Guevara-Aguirre J, Wan J, Passarino G, Kennedy BK, Wei M,

Cohen P, Crimmins EM, Longo VD. Low Protein Intake Is Associated with a Major

Reduction in IGF-1, Cancer, and Overall Mortality in the 65 and Younger but Not

Older Population. Cell Metab. 2014 Mar 4;19(3):407-17. doi:

10.1016/j.cmet.2014.02.006. PubMed PMID: 24606898; PubMed Central PMCID:




17: Brisson BK, Spinazzola J, Park S, Barton ER. Viral expression of insulin-like

growth factor I E-peptides increases skeletal muscle mass but at the expense of

strength. Am J Physiol Endocrinol Metab. 2014 Apr;306(8):E965-74. doi:

10.1152/ajpendo.00008.2014. Epub 2014 Feb 25. PubMed PMID: 24569593.



18: List EO, Berryman DE, Funk K, Jara A, Kelder B, Wang F, Stout MB, Zhi X, Sun

L, White TA, Lebrasseur NK, Pirtskhalava T, Tchkonia T, Jensen EA, Zhang W,

Masternak MM, Kirkland JL, Miller RA, Bartke A, Kopchick JJ. Liver-Specific GH

Receptor Gene Disrupted (LiGHRKO) Mice Have Decreased Endocrine IGF-I, Increased

Local IGF-I, and Altered Body Size, Body Composition, and Adipokine Profiles.

Endocrinology. 2014 Feb 11:en20132086. [Epub ahead of print] PubMed PMID:




19: Tullet JM, Araiz C, Sanders MJ, Au C, Benedetto A, Papatheodorou I, Clark E,

Schmeisser K, Jones D, Schuster EF, Thornton JM, Gems D. DAF-16/FoxO directly

regulates an atypical AMP-activated protein kinase gamma isoform to mediate the

effects of insulin/IGF-1 signaling on aging in Caenorhabditis elegans. PLoS

Genet. 2014 Feb 6;10(2):e1004109. doi: 10.1371/journal.pgen.1004109. eCollection

2014 Feb. PubMed PMID: 24516399; PubMed Central PMCID: PMC3916255.



20: Moody G, Beltran PJ, Mitchell P, Cajulis E, Chung YA, Hwang D, Kendall R,

Radinsky R, Cohen P, Calzone FJ. IGF1R blockade with ganitumab results in

systemic effects on the GH-IGF axis in mice. J Endocrinol. 2014 Mar

17;221(1):145-55. doi: 10.1530/JOE-13-0306. Print 2014. PubMed PMID: 24492468.



21: Beelen K, Opdam M, Severson TM, Koornstra RH, Vincent AD, Wesseling J, Muris

JJ, Berns EM, Vermorken JB, van Diest PJ, Linn SC. PIK3CA mutations, phosphatase

and tensin homolog, human epidermal growth factor receptor 2 and insulin-like

growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal

breast cancer patients. Breast Cancer Res. 2014 Jan 27;16(1):R13. [Epub ahead of

print] PubMed PMID: 24467828; PubMed Central PMCID: PMC3978618.



22: Malaguarnera R, Sacco A, Morcavallo A, Squatrito S, Migliaccio A, Morrione A,

Maggiolini M, Belfiore A. Metformin Inhibits Androgen-Induced IGF-IR

Up-Regulation in Prostate Cancer Cells by Disrupting Membrane-Initiated Androgen

Signaling. Endocrinology. 2014 Apr;155(4):1207-21. doi: 10.1210/en.2013-1925.

Epub 2014 Jan 17. PubMed PMID: 24437490; PubMed Central PMCID: PMC3959597.



23: Abu Shehab M, Damerill I, Shen T, Rosario FJ, Nijland M, Nathanielsz PW,

Kamat A, Jansson T, Gupta MB. Liver mTOR Controls IGF-I Bioavailability by

Regulation of Protein Kinase CK2 and IGFBP-1 Phosphorylation in Fetal Growth

Restriction. Endocrinology. 2014 Apr;155(4):1327-39. doi: 10.1210/en.2013-1759.

Epub 2014 Jan 17. PubMed PMID: 24437487; PubMed Central PMCID: PMC3959599.



24: Wimmer RJ, Liu Y, Schachter TN, Stonko DP, Peercy BE, Schneider MF.

Mathematical modeling reveals modulation of both nuclear influx and efflux of

Foxo1 by the IGF-I/PI3K/Akt pathway in skeletal muscle fibers. Am J Physiol Cell

Physiol. 2014 Mar;306(6):C570-84. doi: 10.1152/ajpcell.00338.2013. Epub 2014 Jan

15. PubMed PMID: 24429066; PubMed Central PMCID: PMC3948977.



25: Cohen P, Weng W, Rogol AD, Rosenfeld RG, Kappelgaard AM, Germak J.

Dose-sparing and safety-enhancing effects of an IGF-I-based dosing regimen in

short children treated with growth hormone in a 2-year randomized controlled

trial: therapeutic and pharmacoeconomic considerations. Clin Endocrinol (Oxf).

2014 Jan 16. doi: 10.1111/cen.12408. [Epub ahead of print] PubMed PMID: 24428305.



26: Kennedy OD, Sun H, Wu Y, Courtland HW, Williams GA, Cardoso L, Basta-Pljakic

J, Schaffler MB, Yakar S. Skeletal response of male mice to anabolic hormone

therapy in the absence of the Igfals gene. Endocrinology. 2014 Mar;155(3):987-99.

doi: 10.1210/en.2013-1819. Epub 2014 Jan 1. PubMed PMID: 24424061; PubMed Central

PMCID: PMC3929729.



27: Mireuta M, Birman E, Barmash M, Pollak M. Quantification of binding of IGF-1

to BI 836845, a candidate therapeutic antibody against IGF-1 and IGF-2, and

effects of this antibody on IGF-1:IGFBP-3 complexes in vitro and in male C57BL/6

mice. Endocrinology. 2014 Mar;155(3):703-15. doi: 10.1210/en.2013-1791. Epub 2014

Jan 1. PubMed PMID: 24424057.



28: Kamenický P, Mazziotti G, Lombès M, Giustina A, Chanson P. Growth hormone,

insulin-like growth factor-1, and the kidney: pathophysiological and clinical

implications. Endocr Rev. 2014 Apr;35(2):234-81. doi: 10.1210/er.2013-1071. Epub

2013 Dec 20. PubMed PMID: 24423979.



29: Högler W, Martin DD, Crabtree N, Nightingale P, Tomlinson J, Metherell L,

Rosenfeld R, Hwa V, Rose S, Walker J, Shaw N, Barrett T, Frystyk J. IGFALS Gene

Dosage Effects on Serum IGF-I and Glucose Metabolism, Body Composition, Bone

Growth in Length and Width, and the Pharmacokinetics of Recombinant Human IGF-I

Administration. J Clin Endocrinol Metab. 2014 Apr;99(4):E703-12. doi:

10.1210/jc.2013-3718. Epub 2014 Jan 13. PubMed PMID: 24423360.



30: Wu J, Yu E. Insulin-like growth factor receptor-1 (IGF-IR) as a target for

prostate cancer therapy. Cancer Metastasis Rev. 2014 Jan 12. [Epub ahead of

print] PubMed PMID: 24414227.



31: Ziegler AN, Chidambaram S, Forbes BE, Wood TL, Levison SW. Insulin-like

growth factor-II (IGF-II) and IGF-II analogs with enhanced insulin receptor-a

binding affinity promote neural stem cell expansion. J Biol Chem. 2014 Feb

21;289(8):4626-33. doi: 10.1074/jbc.M113.537597. Epub 2014 Jan 7. PubMed PMID:

24398690; PubMed Central PMCID: PMC3931023.



32: Kang HS, Ahn SH, Mishra SK, Hong KM, Lee ES, Shin KH, Ro J, Lee KS, Kim MK.

Association of polymorphisms and haplotypes in the insulin-like growth factor 1

receptor (IGF1R) gene with the risk of breast cancer in Korean women. PLoS One.

2014 Jan 2;9(1):e84532. doi: 10.1371/journal.pone.0084532. eCollection 2014.

PubMed PMID: 24392142; PubMed Central PMCID: PMC3879335.



33: Basu S, Rajakaruna S, De Arcangelis A, Zhang L, Georges-Labouesse E, Menko

AS. α6 integrin transactivates insulin-like growth factor receptor-1 (IGF-1R) to

regulate caspase-3-mediated lens epithelial cell differentiation initiation. J

Biol Chem. 2014 Feb 14;289(7):3842-55. doi: 10.1074/jbc.M113.515254. Epub 2013

Dec 31. PubMed PMID: 24381169; PubMed Central PMCID: PMC3924254.



34: Troncoso R, Ibarra C, Vicencio JM, Jaimovich E, Lavandero S. New insights

into IGF-1 signaling in the heart. Trends Endocrinol Metab. 2014

Mar;25(3):128-37. doi: 10.1016/j.tem.2013.12.002. Epub 2013 Dec 28. PubMed PMID:




35: Dai W, Bai Y, Hebda L, Zhong X, Liu J, Kao J, Duan C. Calcium

deficiency-induced and TRP channel-regulated IGF1R-PI3K-Akt signaling regulates

abnormal epithelial cell proliferation. Cell Death Differ. 2014 Apr;21(4):568-81.

doi: 10.1038/cdd.2013.177. Epub 2013 Dec 13. PubMed PMID: 24336047; PubMed

Central PMCID: PMC3950320.



36: Gan Y, Paterson AJ, Zhang Y, Jiang J, Frank SJ. Functional collaboration of

insulin-like growth factor-1 receptor (IGF-1R), but not insulin receptor (IR),

with acute GH signaling in mouse calvarial cells. Endocrinology. 2014

Mar;155(3):1000-9. doi: 10.1210/en.2013-1732. Epub 2013 Jan 1. PubMed PMID:

24302626; PubMed Central PMCID: PMC3929739.



37: Friedbichler K, Hofmann MH, Kroez M, Ostermann E, Lamche HR, Koessl C, Borges

E, Pollak MN, Adolf G, Adam PJ. Pharmacodynamic and antineoplastic activity of BI

836845, a fully human IGF ligand-neutralizing antibody, and mechanistic rationale

for combination with rapamycin. Mol Cancer Ther. 2014 Feb;13(2):399-409. doi:

10.1158/1535-7163.MCT-13-0598. Epub 2013 Dec 2. PubMed PMID: 24296829.



38: Dong CX, Zhao W, Solomon C, Rowland KJ, Ackerley C, Robine S, Holzenberger M,

Gonska T, Brubaker PL. The intestinal epithelial insulin-like growth factor-1

receptor links glucagon-like peptide-2 action to gut barrier function.

Endocrinology. 2014 Feb;155(2):370-9. doi: 10.1210/en.2013-1871. Epub 2013 Nov

21. PubMed PMID: 24265452.



39: El-Ami T, Moll L, Carvalhal Marques F, Volovik Y, Reuveni H, Cohen E. A novel

inhibitor of the insulin/IGF signaling pathway protects from age-onset,

neurodegeneration-linked proteotoxicity. Aging Cell. 2014 Feb;13(1):165-74. doi:

10.1111/acel.12171. Epub 2013 Nov 22. PubMed PMID: 24261972.



40: De Paula ML, Cui QL, Hossain S, Antel J, Almazan G. The PTEN inhibitor

bisperoxovanadium enhances myelination by amplifying IGF-1 signaling in rat and

human oligodendrocyte progenitors. Glia. 2014 Jan;62(1):64-77. doi:

10.1002/glia.22584. Epub 2013 Oct 26. PubMed PMID: 24166839.



41: Wang H, Qin J, Gong S, Feng B, Zhang Y, Tao J. Insulin-like growth factor-1

receptor-mediated inhibition of A-type K(+) current induces sensory neuronal

hyperexcitability through the phosphatidylinositol 3-kinase and extracellular

signal-regulated kinase 1/2 pathways, independently of Akt. Endocrinology. 2014

Jan;155(1):168-79. doi: 10.1210/en.2013-1559. Epub 2013 Dec 20. PubMed PMID:




42: Dwane S, Durack E, O'Connor R, Kiely PA. RACK1 promotes neurite outgrowth by

scaffolding AGAP2 to FAK. Cell Signal. 2014 Jan;26(1):9-18. doi:

10.1016/j.cellsig.2013.08.036. Epub 2013 Sep 19. PubMed PMID: 24056044.



43: van Exel E, Eikelenboom P, Comijs H, Deeg DJ, Stek ML, Westendorp RG.

Insulin-like growth factor-1 and risk of late-onset Alzheimer's disease: findings

from a family study. Neurobiol Aging. 2014 Mar;35(3):725.e7-10. doi:

10.1016/j.neurobiolaging.2013.08.014. Epub 2013 Sep 20. PubMed PMID: 24054991.



44: Kuang X, Chen YS, Wang LF, Li YJ, Liu K, Zhang MX, Li LJ, Chen C, He Q, Wang

Y, Du JR. Klotho upregulation contributes to the neuroprotection of ligustilide

in an Alzheimer's disease mouse model. Neurobiol Aging. 2014 Jan;35(1):169-78.

doi: 10.1016/j.neurobiolaging.2013.07.019. Epub 2013 Aug 21. PubMed PMID:




45: Gong M, Ma J, Guillemette R, Zhou M, Yang Y, Yang Y, Hock JM, Yu X. miR-335

inhibits small cell lung cancer bone metastases via IGF-IR and RANKL pathways.

Mol Cancer Res. 2014 Jan;12(1):101-10. doi: 10.1158/1541-7786.MCR-13-0136. Epub

2013 Aug 21. PubMed PMID: 23966614.



46: Xu J, Gontier G, Chaker Z, Lacube P, Dupont J, Holzenberger M. Longevity

effect of IGF-1R(+/-) mutation depends on genetic background-specific receptor

activation. Aging Cell. 2014 Feb;13(1):19-28. doi: 10.1111/acel.12145. Epub 2013

Sep 11. PubMed PMID: 23898955.



47: Conti A, Espina V, Chiechi A, Magagnoli G, Novello C, Pazzaglia L, Quattrini

I, Picci P, Liotta LA, Benassi MS. Mapping protein signal pathway interaction in

sarcoma bone metastasis: linkage between rank, metalloproteinases turnover and

growth factor signaling pathways. Clin Exp Metastasis. 2014 Jan;31(1):15-24. doi:

10.1007/s10585-013-9605-6. Epub 2013 Jul 23. PubMed PMID: 23877430.



48: Lukanova A, Becker S, Hüsing A, Schock H, Fedirko V, Trepo E, Trichopoulou A,

Bamia C, Lagiou P, Benetou V, Trichopoulos D, Nöthlings U, Tjønneland A, Overvad

K, Dossus L, Teucher B, Boeing H, Aleksandrova K, Palli D, Pala V, Panico S,

Tumino R, Ricceri F, Bueno-de-Mesquita HB, Siersema PD, Peeters PH, Quiros JR,

Duell EJ, Molina-Montes E, Chirlaque MD, Gurrea AB, Dorronsoro M, Lindkvist B,

Johansen D, Werner M, Sund M, Khaw KT, Wareham N, Key TJ, Travis RC, Rinaldi S,

Romieu I, Gunter MJ, Riboli E, Jenab M, Kaaks R. Prediagnostic plasma

testosterone, sex hormone-binding globulin, IGF-I and hepatocellular carcinoma:

etiological factors or risk markers? Int J Cancer. 2014 Jan 1;134(1):164-73. doi:

10.1002/ijc.28342. Epub 2013 Aug 2. PubMed PMID: 23801371.



49: Berryman DE, Lubbers ER, Magon V, List EO, Kopchick JJ. A dwarf mouse model

with decreased GH/IGF-1 activity that does not experience life-span extension:

potential impact of increased adiposity, leptin, and insulin with advancing age.

J Gerontol A Biol Sci Med Sci. 2014 Feb;69(2):131-41. doi: 10.1093/gerona/glt069.

Epub 2013 May 21. PubMed PMID: 23695394.



50: Agis-Balboa RC, Fischer A. Generating new neurons to circumvent your fears:

the role of IGF signaling. Cell Mol Life Sci. 2014 Jan;71(1):21-42. doi:

10.1007/s00018-013-1316-2. Epub 2013 Mar 30. Review. PubMed PMID: 23543251.



51: Azar WJ, Zivkovic S, Werther GA, Russo VC. IGFBP-2 nuclear translocation is

mediated by a functional NLS sequence and is essential for its pro-tumorigenic

actions in cancer cells. Oncogene. 2014 Jan 30;33(5):578-88. doi:

10.1038/onc.2012.630. Epub 2013 Feb 25. PubMed PMID: 23435424.